Jpmorgan Chase & CO Privia Health Group, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Privia Health Group, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 419,306 shares of PRVA stock, worth $10.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
419,306
Previous 398,738 5.16%
Holding current value
$10.1 Million
Previous $7.8 Million 20.76%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
BUY
$19.64 - $25.69 $403,955 - $528,391
20,568 Added 5.16%
419,306 $9.41 Million
Q4 2024

Feb 12, 2025
BUY
$16.82 - $22.8 $3.54 Million - $4.8 Million
210,354 Added 111.66%
398,738 $7.8 Million
Q3 2024

Dec 26, 2024
BUY
$16.95 - $21.29 $248,164 - $311,706
14,641 Added 8.43%
188,384 $3.43 Million
Q3 2024

Nov 08, 2024
BUY
$16.95 - $21.29 $248,164 - $311,706
14,641 Added 8.43%
188,384 $3.43 Million
Q2 2024

Dec 26, 2024
SELL
$16.09 - $19.38 $235,573 - $283,742
-14,641 Reduced 7.77%
173,743 $3.02 Million
Q2 2024

Aug 12, 2024
SELL
$16.09 - $19.38 $2.84 Million - $3.43 Million
-176,799 Reduced 50.44%
173,743 $3.02 Million
Q1 2024

Dec 26, 2024
BUY
$18.97 - $23.71 $3.08 Million - $3.84 Million
162,158 Added 86.08%
350,542 $6.87 Million
Q1 2024

May 10, 2024
BUY
$18.97 - $23.71 $1.88 Million - $2.35 Million
99,110 Added 39.42%
350,542 $6.87 Million
Q4 2023

Dec 26, 2024
BUY
$20.42 - $24.22 $1.29 Million - $1.53 Million
63,048 Added 33.47%
251,432 $5.79 Million
Q4 2023

Feb 12, 2024
SELL
$20.42 - $24.22 $17,887 - $21,216
-876 Reduced 0.35%
251,432 $5.79 Million
Q3 2023

Nov 14, 2023
BUY
$21.63 - $27.92 $1.49 Million - $1.92 Million
68,923 Added 37.58%
252,308 $5.8 Million
Q2 2023

Aug 11, 2023
BUY
$24.01 - $29.93 $800,637 - $998,045
33,346 Added 22.22%
183,385 $4.79 Million
Q1 2023

May 18, 2023
BUY
$21.0 - $28.71 $1.42 Million - $1.94 Million
67,641 Added 82.09%
150,039 $4.14 Million
Q1 2023

May 11, 2023
SELL
$21.0 - $28.71 $1.04 Million - $1.43 Million
-49,668 Reduced 37.61%
82,398 $2.28 Million
Q4 2022

Feb 13, 2023
SELL
$22.29 - $35.91 $224,527 - $361,721
-10,073 Reduced 7.09%
132,066 $3 Million
Q3 2022

Nov 14, 2022
SELL
$28.9 - $42.97 $1.5 Million - $2.23 Million
-51,906 Reduced 26.75%
142,139 $4.84 Million
Q2 2022

Aug 11, 2022
BUY
$18.74 - $29.78 $3 Million - $4.77 Million
160,206 Added 473.44%
194,045 $5.65 Million
Q1 2022

May 11, 2022
BUY
$19.16 - $27.29 $243,945 - $347,456
12,732 Added 60.32%
33,839 $905,000
Q4 2021

Feb 10, 2022
BUY
$21.14 - $32.49 $76,167 - $117,061
3,603 Added 20.58%
21,107 $546,000
Q3 2021

Nov 12, 2021
BUY
$23.56 - $46.78 $412,394 - $818,837
17,504 New
17,504 $413,000

Others Institutions Holding PRVA

# of Institutions
297
Shares Held
102M
Call Options Held
204K
Put Options Held
48.7K
View Full List

About Privia Health Group, Inc.

PRVA Quotes by TradingView
  • Ticker PRVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 111,326,000
  • Market Cap $2.69B
  • Description
  • Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population...
More about PRVA
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email